Literature DB >> 2949697

Inactivation of factor VIII by activated protein C and protein S.

F J Walker, S I Chavin, P J Fay.   

Abstract

Factor VIII was inactivated by activated protein C in the presence of calcium and phospholipids. Analysis of the activated protein C-catalyzed cleavage products of factor VIII indicated that inactivation resulted from the cleavage of the heavy chains. The heavy chains appeared to be converted into 93- and 53-kDa peptides. Inactivation of factor VIII that was only composed of the 93-kDa heavy chain and 83-kDa light chain indicated that the 93-kDa polypeptide could be degraded into a 68-kDa peptide that could be subsequently cleaved into 48- and 23-kDa polypeptides. Thus, activated protein C catalyzed a minimum of four cleavages in the heavy chain. Activated protein C did not appear to alter the factor VIII light chain. The addition of protein S accelerated the rate of inactivation and the rate of all of the cleavages. The effect of protein S could be observed on the cleavage of the heavy chains and on secondary cleavages of the smaller products, including the 93-, 68-, and 53-kDa polypeptides. The addition of factor IX to the factor VIII-activated protein C reaction mixture resulted in the inhibition of factor VIII inactivation. The effect of factor IX was dose dependent. Factor VIII was observed to compete with factor Va for activated protein C. The concentration dependence of factor VIII inhibition of factor Va inactivation suggested that factor VIII and factor Va were equivalent substrates for activated protein C.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949697     DOI: 10.1016/0003-9861(87)90037-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

Review 2.  Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Authors:  R J Kaufman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

Review 3.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

4.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.

Authors:  A L Kuharsky; A L Fogelson
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

5.  Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.

Authors:  N Fernandes; L O Mosnier; L Tonnu; M J Heeb
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

6.  The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.

Authors:  G Manfioletti; C Brancolini; G Avanzi; C Schneider
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  [The clinical importance of protein C and S deficiency for surgical patients].

Authors:  H Rabl; H Fruhwirth
Journal:  Langenbecks Arch Chir       Date:  1992

8.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Cerebral ischemia in a patient with protein S deficiency and carotid stenosis.

Authors:  L C Erli; R Grandi; A Brambilla; M Zadra; B Felice; F Miele; G Finazzi
Journal:  Ital J Neurol Sci       Date:  1994-03

Review 10.  Acquired protein S deficiency.

Authors:  B Kemkes-Matthes
Journal:  Clin Investig       Date:  1992-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.